Upstage to Release Preview of Next-Generation LLM ‘Solar Pro’

1 year ago

- Solar Pro is the most intelligent LLM optimized to run on a single GPU, outperforming models from tech giants…

HomeAid Affiliates Across the Country Collected and Distributed Over 8.3 Million Diapers and Other Essential Baby and Personal Hygiene Items 

1 year ago

HomeAid ‘s Annual Spring and Summer Essentials Drives Deliver Millions of Critical Baby Items to Children and Families Experiencing or…

Applied DNA Launches Mpox Clade I and Clade II Testing Service

1 year ago

STONY BROOK, NY / ACCESSWIRE / September 11, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in…

Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line

1 year ago

BOULDER, CO / ACCESSWIRE / September 11, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing…

Nona Scientific Welcomes Industry Veteran Robb Chapin as Chairman of Newly Launched Advisory Board

1 year ago

Chapin will work closely with CEO Mac McKellar to oversee the company's strategic initiatives, bringing his extensive experience in senior…

Royal Wound-X Receives IRB Approval and Commences Randomized Controlled Trials for Pivotal Products

1 year ago

HACKENSACK, NJ / ACCESSWIRE / September 11, 2024 / Royal Wound-X, a division of Royal Biologics dedicated to advancing wound…

Modular Medical Announces Finalization of Protocol for GLP-1 Personalized Metabolic Therapy Study Utilizing the MODD1 Platform

1 year ago

-Proof of Concept Study in Rapid Acting GLP-1 to commence in October 2024 with data expected in November 2024-Pre-clinical study…

Compassion Center and SIDHE Research Institute Take the Lead in Ethical Hallucinogen Research to Revolutionize Mental Health Treatment

1 year ago

Compassion Center and SIDHE Research Institute are pioneering a new era of mental health care through ethical hallucinogen research. By…

MIRA Pharmaceuticals Designates Neuropathic Pain as Primary Indication for Ketamir-2 and Submits Pre-IND Meeting Request to FDA

1 year ago

MIAMI, FL / ACCESSWIRE / September 11, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company focused on developing…